JENNIFER DURHAM: Open Payments
NPI 1457399206 · RESTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 22 payments from 12 companies in 2025. Trend: 2023 $319 · 2024 $693 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $181 |
| Novartis Pharmaceuticals Corporation | 5 | $148 |
| Abbott Laboratories | 1 | $127 |
| PFIZER INC. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Amgen Inc. | 2 | $43 |
| Novo Nordisk Inc | 1 | $31 |
| Recor Medical Inc | 1 | $27 |
| Boston Scientific Corporation | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $22 |
Products named: WAINUA, LEQVIO, CARDIOMEMS, ELIQUIS, REPATHA, Wegovy, Paradise Ultrasound Renal Denervation System, CAMZYOS.
Industry payments across VA — which companies pay providers there.
